Immunogenicity and tolerance following HIV-1/HBV plant-based oral vaccine administration

Abstract Transgenic tobacco plants expressing a HIV-1 polyepitope associated with hepatitis B (HBV) virus-like particles (VLPs) were previously described. It is demonstrated here that oral administration of these transgenic plants to humanized HSB mice to boost DNA-priming can elicit anti-HIV-1 spec...

Full description

Saved in:
Bibliographic Details
Published inVaccine Vol. 26; no. 35; pp. 4477 - 4485
Main Authors Guetard, Denise, Greco, Raffaella, Cervantes Gonzalez, Minerva, Celli, Susanna, Kostrzak, Anna, Langlade-Demoyen, Pierre, Sala, Francesco, Wain-Hobson, Simon, Sala, Monica
Format Journal Article
LanguageEnglish
Published Oxford Elsevier Ltd 18.08.2008
Elsevier
Elsevier Limited
Subjects
HBV
HIV
HBV
Online AccessGet full text

Cover

Loading…
More Information
Summary:Abstract Transgenic tobacco plants expressing a HIV-1 polyepitope associated with hepatitis B (HBV) virus-like particles (VLPs) were previously described. It is demonstrated here that oral administration of these transgenic plants to humanized HSB mice to boost DNA-priming can elicit anti-HIV-1 specific CD8+ T cell activation detectable in mesenteric lymph nodes. Nevertheless, a significant regulatory T cell activation was induced in vivo by the vaccination protocols. The balance between tolerance and immunogenicity remains the main concern in the proof of concept of plant-based vaccine.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0264-410X
1873-2518
0264-410X
DOI:10.1016/j.vaccine.2008.06.059